Allscripts Healthcare Stock
Your prediction
Pros and Cons of Allscripts Healthcare in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Allscripts Healthcare vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Allscripts Healthcare | - | - | - | - | - | - | - |
| MicroVision Inc | -10.130% | -34.746% | -39.348% | -66.282% | -54.663% | -94.784% | -97.960% |
| Simulations Plus | -1.450% | -5.556% | -9.333% | -63.243% | -11.688% | -63.243% | -67.925% |
| Fluidigm Corp. | -8.880% | 0.000% | 18.902% | 12.717% | -8.019% | -54.439% | -78.058% |
Comments
Veradigm Inc. (NASDAQ: MDRX) had its price target lowered by analysts at TD Cowen from $26.00 to $15.00. They now have a "buy" rating on the stock.
Show more
Ratings data for MDRX provided by MarketBeat
Veradigm Inc. (NASDAQ: MDRX) had its price target lowered by analysts at Royal Bank of Canada from $22.00 to $11.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for MDRX provided by MarketBeat